Label Information
Modified Live Virus
For use in dogs only

DESCRIPTION: NEOPAR® is for the vaccination of healthy dogs against disease due to canine parvovirus. NEOPAR® is designed to be used primarily where the severe threat of canine parvovirus infections exists in the resident dog population.
NEOPAR® is a modified live virus vaccine containing a high antigenic mass per dose of a highly immunogenic strain of canine parvovirus. This vaccine gives reliable protection against infections by other known strains of canine parvovirus.
NEOPAR® overrides moderate to high antibody levels such as those found in puppies having maternal antibodies or in dogs from pre-existing vaccination. It can be used successfully as a booster for a pre-existing vaccination.
Puppies vaccinated with NEOPAR® generated high levels of the IgM and IgG classes of antibodies. Secretory immunity was engendered in the gut. Reversion to virulence does not occur. Field studies indicate that this vaccine is safe in puppies 3 weeks of age or older.

DOSAGE: Aseptically inject 1ml subcutaneously or intramuscularly into healthy dogs. Administer the initial dose at or about 42 days of age. Because there is potential for maternal antibody to interfere with the immune response to the original vaccination, revaccinate every 14 to 21 days until the dog is 18 weeks of age. Dogs over 18 weeks should receive a single dose (1ml). Revaccinate annually with one dose.

PRECAUTIONS: Store between 2° and 7°C (35° and 45°F). Do not freeze. Shake well before using. Use entire contents when first opened. Do not vaccinate pregnant bitches or obviously sick or debilitated dogs. The use of this vaccine may produce anaphylaxis and/or other inflammatory reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction. Gentamicin and Amphotericin B are used as preservatives. Burn this container and all unused contents. For Veterinary use only.